Drug Shortage Report for RESTASIS
| Report ID | 180339 |
| Drug Identification Number | 02355655 |
| Brand name | RESTASIS |
| Common or Proper name | Restasis 0.05% |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOSPORINE |
| Strength(s) | 0.05% |
| Dosage form(s) | EMULSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 30 x 0.4 mL and 60 x 0.4 mL |
| ATC code | S01XA |
| ATC description | OTHER OPHTHALMOLOGICALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-01-10 |
| Actual start date | 2023-01-10 |
| Estimated end date | 2023-01-27 |
| Actual end date | 2023-01-26 |
| Shortage status | Resolved |
| Updated date | 2023-01-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2023-01-27 | English | Compare |
| v11 | 2023-01-26 | French | Compare |
| v10 | 2023-01-26 | English | Compare |
| v9 | 2023-01-11 | English | Compare |
| v8 | 2023-01-10 | French | Compare |
| v7 | 2023-01-10 | English | Compare |
| v6 | 2023-01-10 | French | Compare |
| v5 | 2023-01-10 | English | Compare |
| v4 | 2023-01-10 | French | Compare |
| v3 | 2023-01-10 | English | Compare |
| v2 | 2023-01-10 | English | Compare |
| v1 | 2023-01-10 | English | Compare |
Showing 1 to 12 of 12